April 2018 New England Journal of Medicine publication that discusses KEYTRUDA® (pembrolizumab) Injection 100 mg.
CLICK HERE to access the April 2018 New England Journal of Medicine publication which discusses KEYTRUDA® (pembrolizumab) Injection 100 mg.